Innovex Biosciences, Inc

Cytokinetics is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. The company s focus on the cytoskeleton enables it to develop novel and potentially safer and more effective classes of drugs directed at treatments for cancer, cardiovascular disease and other diseases. The company has developed a cell biology driven approach and proprietary technologies to evaluate the function of many interacting proteins in the complex environment of the intact human cell. The approach has yielded novel small molecule drug candidates that are in clinical development and two novel small molecule potential drug candidates in development, one in cancer and the other for heart failure. Its most advanced drug candidate, ispinesib is the subject of a Phase II clinical trials program designed to evaluate its effectiveness in many different types of cancer. Cytokinetics is headquartered in South San Francisco.

Hoffmann-La Roche, also known as Roche, is prescription drug unit that provides more than 35 medications in the United States in therapeutic areas, including dermatology, oncology, transplantation, AIDS, central nervous system disorders, and cardiovascular and infectious diseases. It offers products that include Accutane, Boniva, CellCept, Copegus, Cytovene, Demadex EC-Naprosyn, Romazicon, Tamiflu, Ticlid, Valcyte, Valium, Xeloda, Xenical and Zenapax. The company operates over five research centers in New Jersey and California in the United States, as well as Switzerland, Germany and China. Hoffmann-La Roche works with a team of nearly 5,000 employees. It is a part of Roche Group, which is one of the world's leading research-oriented health care groups with core businesses in pharmaceuticals and diagnostics. Operational for more than 100 years, the parent company develops a range of products and services that address prevention, diagnosis and treatment of diseases.

Portola Pharmaceuticals is a Bay Area–based pharmaceuticals company with a focus on bioresearch and drug development. Their efforts are directed towards global markets, specifically in the treatment of cardiovascular disease and inflammation. Generated from their available business information